Thermo Fisher Scientific Balance Sheet Health
Financial Health criteria checks 3/6
Thermo Fisher Scientific has a total shareholder equity of $49.1B and total debt of $35.3B, which brings its debt-to-equity ratio to 71.9%. Its total assets and total liabilities are $100.4B and $51.3B respectively. Thermo Fisher Scientific's EBIT is $7.4B making its interest coverage ratio 24.4. It has cash and short-term investments of $6.6B.
Key information
71.9%
Debt to equity ratio
US$35.31b
Debt
| Interest coverage ratio | 24.4x |
| Cash | US$6.65b |
| Equity | US$49.10b |
| Total liabilities | US$51.27b |
| Total assets | US$100.36b |
Recent financial health updates
These 4 Measures Indicate That Thermo Fisher Scientific (NYSE:TMO) Is Using Debt Reasonably Well
Sep 21
Is Thermo Fisher Scientific (NYSE:TMO) A Risky Investment?
Jun 18We Think Thermo Fisher Scientific (NYSE:TMO) Can Stay On Top Of Its Debt
Mar 12Recent updates
Thermo Fisher Scientific: Near The Bottom And Attractively Valued
Nov 14Thermo Fisher Scientific Q3: Expecting Market Recovery In FY25; Upgrade To 'Buy'
Oct 23Thermo Fisher Scientific: Fantastic Company, Rich Valuation
Oct 04These 4 Measures Indicate That Thermo Fisher Scientific (NYSE:TMO) Is Using Debt Reasonably Well
Sep 21Thermo Fisher Scientific Inc.'s (NYSE:TMO) Price Is Out Of Tune With Earnings
Aug 16Thermo Fisher Scientific: Microscopic Signs Of Growth Emerging
Jul 25A Look At The Fair Value Of Thermo Fisher Scientific Inc. (NYSE:TMO)
Jul 11Is Thermo Fisher Scientific (NYSE:TMO) A Risky Investment?
Jun 18Low Yield, High Growth: Unveiling The Power Of Thermo Fisher's Dividends
Jun 07Thermo Fisher: Renewed Growth Yet To Materialize, But Already Priced In (Rating Downgrade)
Apr 30Thermo Fisher Scientific Inc. (NYSE:TMO) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Apr 27Why Thermo Fisher Scientific Inc. (NYSE:TMO) Could Be Worth Watching
Apr 24Thermo Fisher Scientific: Too Hot To Handle
Apr 15Investors Still Waiting For A Pull Back In Thermo Fisher Scientific Inc. (NYSE:TMO)
Apr 02We Think Thermo Fisher Scientific (NYSE:TMO) Can Stay On Top Of Its Debt
Mar 12Thermo Fisher's Bright Future Makes It A Great Buy On Weakness
Feb 06Here's What Analysts Are Forecasting For Thermo Fisher Scientific Inc. (NYSE:TMO) After Its Yearly Results
Feb 02Thermo Fisher: Blue Chip Stock Melded With Growth Characteristics
Jan 16Thermo Fisher: Downturn In Pharma And Biotech And Weak China Growth; Initiate With 'Hold'
Jan 06Is Now An Opportune Moment To Examine Thermo Fisher Scientific Inc. (NYSE:TMO)?
Dec 29Financial Position Analysis
Short Term Liabilities: TMO's short term assets ($23.8B) exceed its short term liabilities ($14.6B).
Long Term Liabilities: TMO's short term assets ($23.8B) do not cover its long term liabilities ($36.7B).
Debt to Equity History and Analysis
Debt Level: TMO's net debt to equity ratio (58.4%) is considered high.
Reducing Debt: TMO's debt to equity ratio has increased from 58.2% to 71.9% over the past 5 years.
Debt Coverage: TMO's debt is well covered by operating cash flow (25.8%).
Interest Coverage: TMO's interest payments on its debt are well covered by EBIT (24.4x coverage).